BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10325340)

  • 1. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.
    Reinert RR; von Eiff C; Kresken M; Brauers J; Hafner D; Al-Lahham A; Schorn H; Lütticken R; Peters G;
    J Clin Microbiol; 2001 May; 39(5):1928-31. PubMed ID: 11326015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
    Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.
    Han XY; Kamana M; Rolston KV
    J Clin Microbiol; 2006 Jan; 44(1):160-5. PubMed ID: 16390964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus mitis/oralis Causing Blood Stream Infections in Pediatric Patients.
    Basaranoglu ST; Ozsurekci Y; Aykac K; Aycan AE; Bıcakcigil A; Altun B; Sancak B; Cengiz AB; Kara A; Ceyhan M
    Jpn J Infect Dis; 2019 Jan; 72(1):1-6. PubMed ID: 30175731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents.
    Smith A; Jackson MS; Kennedy H
    Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
    Ergin A; Eser ÖK; Hasçelik G
    New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
    Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
    BMC Infect Dis; 2013 Jun; 13():273. PubMed ID: 23773209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).
    Gordon KA; Beach ML; Biedenbach DJ; Jones RN; Rhomberg PR; Mutnick AH
    Diagn Microbiol Infect Dis; 2002 Jun; 43(2):157-62. PubMed ID: 12088624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
    Piérard D; de Meyer A; Lauwers S
    Pathol Biol (Paris); 1994 May; 42(5):471-4. PubMed ID: 7824316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
    McWhinney PH; Patel S; Whiley RA; Hardie JM; Gillespie SH; Kibbler CC
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2493-5. PubMed ID: 8285642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
    Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
    Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
    Mogi A; Nishi JI; Yoshinaga M; Harada H; Narahara S; Kawakami K; Maruyama I
    Pediatr Infect Dis J; 1997 Dec; 16(12):1140-4. PubMed ID: 9427459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
    Ioannidou S; Tassios PT; Kotsovili-Tseleni A; Foustoukou M; Legakis NJ; Vatopoulos A
    Int J Antimicrob Agents; 2001 Mar; 17(3):195-201. PubMed ID: 11282264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.